ABSENCE OF POINT MUTATIONS IN A FUNCTIONALLY IMPORTANT PART OF THE EXTRACELLULAR DOMAIN OF THE C-KIT PROTOONCOGENE IN A SERIES OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)

被引:0
|
作者
ARLAND, M [1 ]
FIEDLER, W [1 ]
SAMALECOS, A [1 ]
HOSSFELD, DK [1 ]
机构
[1] UNIV HAMBURG,HOSP EPPENDORF,DEPT HEMATOL ONCOL,D-20246 HAMBURG,GERMANY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The proto-oncogenes c-fms and c-kit belong to a family of growth factor receptors possessing protein kinase activity. It has been shown that transfection of a c-fms gene carrying a point mutation at codon 301, leads to a ligand-independent transformation of mouse NIH3T3 cells. In human acute myeloid leukemia (AML), point mutations at codon 301 of the c-fms gene have been observed implying an important role in the transformation process. The possibility of a point mutation of the c-kit proto-oncogene was investigated. We sequenced a segment of the c-kit proto-oncogene coding for a part of the extracellular domain. This segment was 40.7% homologous to the c-fms region encompassing codon 301. c-DNA was prepared from peripheral blood or bone marrow cells from 25 patients with AML, from four patients with myelodysplastic syndrome (MDS) and from three human myeloid cell lines. The region of interest was amplified with two rounds of polymerase chain reactions (PCR) with nested primers and directly sequenced. No point mutations were found in the investigated samples. Thus, point mutations in this segment of the c-kit gene do not seem to play an important role in the transformation process of human acute leukemia.
引用
收藏
页码:498 / 501
页数:4
相关论文
共 50 条
  • [31] INCIDENCE OF C-KIT AND FLT-3 MUTATIONS IN PATIENTS WITH DIFFERENT SUBTYPES OF ACUTE MYELOID LEUKAEMIA
    Zaker, F.
    Mohammadzadeh, M.
    Mohammadi, M.
    Alimoghadam, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 461 - 461
  • [32] c-Kit overexpression is linked to high level of bcl-2 and worse clinical outcome in acute myeloid leukemia (AML)
    Del Poeta, G
    Venditti, A
    Buccisano, F
    Tamburini, A
    Cox, MC
    Aronica, G
    Maurillo, L
    Bruno, A
    Epiceno, AM
    Del Moro, B
    Suppo, G
    Masi, M
    Amadori, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 102 - 102
  • [33] C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice
    Wang, Yue-Ying
    Zhao, Li-Juan
    Wu, Chuan-Feng
    Liu, Ping
    Shi, Lin
    Liang, Yang
    Xiong, Shu-Min
    Mi, Jian-Qing
    Chen, Zhu
    Ren, Ruibao
    Chen, Sai-Juan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (06) : 2450 - 2455
  • [34] Mutation analysis of c-kit in patients with systemic mastocytosis, myelodysplastic syndromes, and acute myeloid leukemia.
    Fritsche-Polanz, R
    Sperr, W
    Valent, P
    Lechner, K
    Födinger, M
    BLOOD, 1999, 94 (10) : 485A - 485A
  • [35] The Significance of c-KIT Mutations Depends on Mutant Level Instead of Positivity in Core Binding Factor Acute Myeloid Leukemia
    Jang, W.
    Chae, H.
    Kim, M.
    Kim, Y.
    Park, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 773 - 773
  • [36] CLONAL ANALYSIS OF MULTIPLE POINT MUTATIONS IN THE N-RAS GENE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    KUBO, K
    NAOE, T
    KIYOI, H
    FUKUTANI, H
    KATO, Y
    OGURI, T
    YAMAMORI, S
    AKATSUKA, Y
    KODERA, Y
    OHNO, R
    JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (04): : 379 - 387
  • [37] ABSENCE OF GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT BY LEUKOCYTES TRANSFUSED - A PROSPECTIVE RANDOMIZED TRIAL IN ACUTE MYELOID-LEUKEMIA (AML) PATIENTS
    NOROL, F
    PARQUET, N
    KUENTZ, M
    BIERLING, P
    CORDONNIER, C
    BEAUJEAN, F
    DUEDARI, N
    VERNANT, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (04) : 591 - 593
  • [38] NPM1, FLT3, and c-KIT Mutations in Pediatric Acute Myeloid Leukemia in Russian Population
    Yatsenko, Yuliya
    Kalennik, Olga
    Maschan, Mikhail
    Kalinina, Irina
    Maschan, Alexey
    Nasedkina, Tatyana
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (03) : E100 - E108
  • [39] FLT3 TYROSINE KINASE DOMAIN (TKD) MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Markova, J.
    Michkova, P.
    Maaloufova, J.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 550 - 550
  • [40] A phase II pilot study of Gleevec/Glivec (imatinib mesylate, STI-571) in patients with c-kit positive acute myeloid leukemia (AML).
    Fischer, T
    Beck, J
    Duyster, J
    Peschel, C
    Müller-Navia, J
    Jäger, E
    Knuth, A
    Gschaidmeier, H
    Huber, C
    BLOOD, 2002, 100 (11) : 561A - 561A